Vikram Thermo (India) Limited
BSE: VIKRAMTH
Prev Close
154.95
Open Price
155.9
Volume
25,289
Today Low / High
130.6 / 157.7
52 WK Low / High
126.85 / 216.45
Range
142 - 157
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 149.85, reflecting a change of -5.1 (-3.29138%). The expected target range on the BSE is 142 - 157. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Vikram Thermo (India) Limited Graph
Vikram Thermo (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vikram Thermo (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 149.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 149.85 | 151.35 | 136.21 - 166.48 |
152.85 | 122.28 - 183.42 | ||
154.35 | 108.04 - 200.65 | ||
Bearish Scenario | 149.85 | 148.35 | 133.52 - 163.19 |
146.85 | 117.48 - 176.22 | ||
145.35 | 101.75 - 188.96 |
Overview of Vikram Thermo (India) Limited
ISIN
INE337E01010
Industry
Medical - Pharmaceuticals
Vol.Avg
18,999
Market Cap
4,858,891,110
Last Dividend
0.75
Official Website
IPO Date
DCF Diff
134.76
DCF
20
Financial Ratios Every Investor Needs
Stock Dividend of VIKRAMTH
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2024-09-23 | September 23, 24 | 0.75 | 0.75 | 2024-09-23 | 2024-10-30 | |
2023-09-15 | September 15, 23 | 0.5 | 0.5 | 2023-09-15 | 2023-10-22 | |
2022-09-08 | September 08, 22 | 0.3 | 0.3 | 2022-09-10 | 2022-10-17 | |
2021-09-23 | September 23, 21 | 0.3 | 1.5 | 2021-09-24 | 2021-10-30 | |
2020-09-22 | September 22, 20 | 0.3 | 1.5 | 2020-09-23 | 2020-10-29 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 126.23 Cr | 65.17 Cr | 61.06 Cr | 0.4837 | 0.00 Cr | 0.00 Cr | 42.17 Cr | 8.10 Cr | 2.58 | 22.26 Cr | 0.0642 |
2024-03-31 | 124.95 Cr | 64.32 Cr | 60.63 Cr | 0.4852 | 0.16 Cr | 1.68 Cr | 34.24 Cr | 25.38 Cr | 8.09 | 38.69 Cr | 0.2031 |
2023-03-31 | 110.38 Cr | 61.30 Cr | 49.07 Cr | 0.4446 | 0.07 Cr | 1.47 Cr | 23.24 Cr | 16.91 Cr | 5.39 | 27.41 Cr | 0.1532 |
2022-03-31 | 91.53 Cr | 60.96 Cr | 30.57 Cr | 0.3340 | 0.09 Cr | 0.74 Cr | 11.44 Cr | 8.69 Cr | 2.77 | 15.44 Cr | 0.0949 |
2021-03-31 | 72.53 Cr | 38.78 Cr | 33.74 Cr | 0.4652 | 0.06 Cr | 1.22 Cr | 15.65 Cr | 12.07 Cr | 3.85 | 18.54 Cr | 0.1664 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 0.52 Cr | 145.89 Cr | 24.44 Cr | 121.4523 Cr | 6.40 Cr | 5.87 Cr | 10.64 Cr | 45.16 Cr | 0.00 Cr | 0.00 Cr | 0.16 Cr | 20.0683 Cr |
2024-03-31 | 3.18 Cr | 142.68 Cr | 29.15 Cr | 113.5274 Cr | 7.04 Cr | 3.86 Cr | 14.66 Cr | 66.09 Cr | 2.26 Cr | 0.00 Cr | 1.00 Cr | 20.9753 Cr |
2023-03-31 | 3.30 Cr | 127.21 Cr | 37.53 Cr | 89.6768 Cr | 18.51 Cr | 15.21 Cr | 9.93 Cr | 64.69 Cr | 0.92 Cr | 0.00 Cr | 1.00 Cr | 27.2246 Cr |
2022-03-31 | 1.38 Cr | 104.35 Cr | 30.88 Cr | 73.4704 Cr | 14.91 Cr | 13.53 Cr | 11.64 Cr | 53.78 Cr | 1.79 Cr | 0.00 Cr | -10.28 Cr | 19.4198 Cr |
2021-03-31 | 0.15 Cr | 92.33 Cr | 26.64 Cr | 65.6916 Cr | 10.43 Cr | 10.28 Cr | 9.08 Cr | 50.52 Cr | 2.58 Cr | 0.00 Cr | -9.85 Cr | 18.1178 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 22.9673 Cr | -22.6881 Cr | -2.9982 Cr | -16.6435 Cr | 0.0000 Cr | 0.5243 Cr | -39.6294 Cr | 8.4177 Cr | -0.6462 Cr | -2.3518 Cr | -0.4539 Cr |
2024-03-31 | 22.1942 Cr | -9.5752 Cr | -13.0380 Cr | 15.3602 Cr | -0.4188 Cr | 2.8807 Cr | -6.8340 Cr | 25.3787 Cr | -11.4702 Cr | -1.5679 Cr | -4.7330 Cr |
2023-03-31 | 13.0545 Cr | -12.6256 Cr | 1.4885 Cr | 0.2919 Cr | 1.9174 Cr | 3.2995 Cr | -12.7626 Cr | 23.0350 Cr | 3.5990 Cr | -0.9407 Cr | 1.7124 Cr |
2022-03-31 | 6.0367 Cr | -7.4625 Cr | 2.6608 Cr | -0.6839 Cr | 1.2351 Cr | 1.3821 Cr | -6.7206 Cr | 11.7654 Cr | 4.4864 Cr | -0.9407 Cr | -2.5599 Cr |
2021-03-31 | 14.8460 Cr | -19.3593 Cr | 3.1535 Cr | 4.0852 Cr | -1.3598 Cr | 0.1470 Cr | -10.7608 Cr | 15.9906 Cr | 4.6228 Cr | -0.9407 Cr | -1.6932 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 28.14 Cr | 11.37 Cr | 16.77 Cr | 0.5961 | 12.67 Cr | 4.07 Cr | 1.30 | 7.74 Cr | 0.1448 |
2024-12-31 | 34.32 Cr | 14.05 Cr | 20.27 Cr | 0.5905 | 12.70 Cr | 10.07 Cr | 3.21 | 13.89 Cr | 0.2934 |
2024-09-30 | 33.66 Cr | 13.89 Cr | 19.77 Cr | 0.5872 | 11.84 Cr | 9.79 Cr | 3.12 | 12.45 Cr | 0.2908 |
2024-06-30 | 31.15 Cr | 14.90 Cr | 16.24 Cr | 0.5216 | 10.95 Cr | -15.83 Cr | -5.05 | -11.79 Cr | -0.5084 |
2024-03-31 | 31.47 Cr | 19.99 Cr | 11.48 Cr | 0.3649 | 6.26 Cr | 4.93 Cr | 1.57 | 7.49 Cr | 0.1568 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 0.52 Cr | 0.00 Cr | 0.52 Cr | 44.24 Cr | 10.64 Cr | 62.76 Cr | 45.16 Cr | 145.89 Cr | 24.44 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 17.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -105.15 Cr |
2024-09-30 | 1.62 Cr | 16.18 Cr | 17.80 Cr | 0.00 Cr | 9.71 Cr | 73.99 Cr | 42.53 Cr | 130.34 Cr | 25.20 Cr |
2024-06-30 | 0.00 Cr | 0.00 Cr | 18.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -113.53 Cr |
2024-03-31 | 3.18 Cr | 14.96 Cr | 18.15 Cr | 40.48 Cr | 14.66 Cr | 74.91 Cr | 66.09 Cr | 142.68 Cr | 29.15 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | 10.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 9.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | -15.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 4.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-12-31 | 6.44 Cr | 1.78 Cr | 0.00 Cr | 0.00 Cr | 1.78 Cr | 2.24 Cr | 0.46 Cr | 0.00 Cr | 1.78 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
2024-05-21 | May 21, 24 | 1753:1000 |
2022-05-12 | May 12, 22 | 5:1 |
Similar Stocks: Medical - Pharmaceuticals
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1985
Gender: Not Specified
Year Born: 1977
Gender: male
Year Born:
Gender: male
Year Born: 1963
FAQs about Vikram Thermo (India) Limited
The CEO is Dhirajlal Karsandas Patel MBA.
The current price is ₹154.95.
The range is ₹126.85-216.45.
The market capitalization is ₹485.89 crores.
The dividend yield is 0.48%.
The P/E ratio is 59.97.
The company operates in the Healthcare sector.
Overview of Vikram Thermo (India) Limited (ISIN: INE337E01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹485.89 crores and an average daily volume of 18,999 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.75.